Clinical trials
Withdrawn Rectal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 4 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 5 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 61 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| City of Hope Medical Center | 3 |
| Case Comprehensive Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| Roswell Park Cancer Institute | 2 |
| Ruijin Hospital | 2 |
| SWOG Cancer Research Network | 2 |
| Stanford University | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| University of Chicago | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Rectal Neoplasms | 61 |
| Colonic Neoplasms | 26 |
| Colorectal Neoplasms | 22 |
| Neoplasm Metastasis | 6 |
| Pancreatic Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Uterine Cervical Neoplasms | 3 |
| Esophageal Neoplasms | 2 |
| Gastrointestinal Neoplasms | 2 |
| Adenomyosis | 1 |
Trials
Showing 76 to 61 of 61. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.